Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten P. Vahl October 29, 2024
Presentation TCT 2024 TCT 1504: Valve-in-Valve TAVR as a Treatment in Very Late, Anterograde Migration of a Transcatheter Aortic Valve Presenter: Aaron Kunamalla October 29, 2024
Presentation TCT 2024 TCT 838: Clinical Futility in Patients With Active Malignancy Undergoing Trans-Catheter Aortic Valve Replacement After Multidisciplinary Heart Team Decision Presenter: Enrico Romagnoli October 29, 2024
Presentation TCT 2024 TCT 1454: Complex TAVI Case: Left Ventricular Wire Loss Solved by Antegrade and Retrograde Approach Presenter: Clara Fernandez Cordon October 29, 2024
Presentation TCT 2024 Are Late Complications of TAVR Unavoidable? A Personal Perspective Presenter: Eric Van Belle October 29, 2024
Presentation TCT 2024 TCT 1286: Very Late Coronary Obstruction After Valve in Valve TAVR With S3U Valve in Trifecta Valve Presenter: Mahmoud Khalil October 29, 2024
Presentation TCT 2024 TCT 1396: Complications and Near Miss in TAVR: Complications One After Another: Ultimately What Ends Well Is Well Presenter: Sanjay Mehrotra October 29, 2024
Presentation TCT 2024 TCT 1382: Inferior STEMI Due to Late Coronary Occlusion in a Degenerated TAVR Presenter: Victor Alfonso Jimenez Diaz October 29, 2024
Presentation TCT 2024 TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry Presenter: Yasser M. Sammour October 29, 2024
Presentation TCT 2024 TCT 909: Cusp Overlap Technique Is Safe and Effective in Edwards Balloon Expandable S3 TAVR Presenter: Nirat Beohar October 29, 2024